"The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are"...
Simulect Patient Information including How Should I Take
In this Article
- What is basiliximab (Simulect)?
- What are the possible side effects of basiliximab (Simulect)?
- What is the most important information I should know about basiliximab (Simulect)?
- What should I discuss with my health care provider before taking basiliximab (Simulect)?
- How should I take basiliximab (Simulect)?
- What happens if I miss a dose (Simulect)?
- What happens if I overdose (Simulect)?
- What should I avoid while taking basiliximab (Simulect)?
- What other drugs will affect basiliximab (Simulect)?
- Where can I get more information?
What should I discuss with my health care provider before taking basiliximab (Simulect)?
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether basiliximab passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I take basiliximab (Simulect)?
Basiliximab is given as an injection through a needle placed into a vein. You will receive this injection just before your transplant and again 4 days afterward. The medicine must be given slowly through an IV infusion, and can take up to 30 minutes to complete.
Basiliximab can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. It is important that you not miss any scheduled visits to your doctor after your transplant.
Additional Simulect Information
- Simulect Drug Interactions Center: basiliximab iv
- Simulect Side Effects Center
- Simulect Overview including Precautions
- Simulect FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.